Načítá se...
Opioid agonist treatment and fatal overdose risk in a statewide U.S. population receiving opioid use disorder services
BACKGROUND AND AIMS: Evidence from randomized controlled trials establishes that medication treatment with methadone and buprenorphine reduces opioid use and improves treatment retention. However, little is known about the role of such medications compared with non-medication treatments in mitigatin...
Uloženo v:
| Vydáno v: | Addiction |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426244/ https://ncbi.nlm.nih.gov/pubmed/32096302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.14991 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|